ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Ralph Steinman Wins Nobel Prize Three Days After His Death

October 14, 2011

Letter to the Editor

February 21, 2003

Researchers Identify Mutation Linked to Inherited Risk of ALL

September 27, 2013

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

ACS President Huerta Disagrees With Staff On Cell Phone Danger.

August 1, 2008

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005